Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Ownership - Who Owns Conduit Pharmaceuticals?

153 Followers

Conduit Pharmaceuticals (CDT) Ownership Overview

6.38%0.79%0.08%0.66%92.09%
0.08% Other Institutional Investors
0.66% ETFs
92.09% Public Companies and
Individual Investors
The ownership structure of Conduit Pharmaceuticals (CDT) stock is a mix of institutional, retail, and individual investors. Approximately 1.53% of the company’s stock is owned by Institutional Investors, 6.38% is owned by Insiders, and 92.09% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 07, 2024
Nirland Limited
>10% Owner
xxxxxxxxxxxxx
$380800
Oct 02, 2024
Nirland Limited
>10% Owner
xxxxxxxxxxxxx
$292836
Sep 19, 2024
Andrew Regan
Director, >10% Owner
xxxxxxxxxxxxx
$4487011

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,092,000Insider6.05%657,936
329,464Institution0.33%35,582
320,741Institution0.32%34,640
244,277Insider0.24%26,382
237,514Institution0.24%25,652
202,934Institution0.20%21,917
129,998Institution0.13%14,040
113,741Institution0.11%12,284
53,111Institution0.05%5,736
52,272Insider0.05%5,645

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
237,514Institution0.24%25,652
202,934Institution0.20%21,917
129,998Institution0.13%14,040
113,741Institution0.11%12,284
53,111Institution0.05%5,736
45,000Institution0.04%4,860
9,620Institution<0.01%1,039
3,284Institution<0.01%355
310Institution<0.01%33
185Institution<0.01%20

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
202,934Institution0.20%24,048
105,391Institution0.10%12,489
110,806Institution0.11%12,022
107,279Institution0.11%11,640
104,209Institution0.10%11,307
13,357Institution0.01%1,583
7,782Institution<0.01%922
8,478Institution<0.01%814
1,894Institution<0.01%182
244Institution<0.01%23

FAQ

Who Owns Conduit Pharmaceuticals (CDT)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 6.38% is held by insiders, and 92.09% is held by retail investors.
    What percentage of Conduit Pharmaceuticals (CDT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.08% of Conduit Pharmaceuticals (CDT) stock is held by institutional investors.
      What percentage of Conduit Pharmaceuticals (CDT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 92.09% of Conduit Pharmaceuticals (CDT) stock is held by retail investors.
        Who owns the most shares of Conduit Pharmaceuticals (CDT)?
        Nirland Limited owns the most shares of Conduit Pharmaceuticals (CDT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis